{"id":164711,"title":"ARCHIVED - Varizig™ as the Varicella Zoster Immune Globulin for the Prevention of Varicella In At-Risk Patients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T14:19:50.928000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2006-32/varizig-varicella-zoster-immune-globulin-prevention-varicella-risk-patients.html?wbdisable=true","snippet":"ARCHIVED - Varizig™ as the Varicella Zoster Immune Globulin for the Prevention of Varicella In At-Risk Patients - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs…","rawSnapshotUrl":"/api/snapshots/raw/164711","browseUrl":"https://replay.healtharchive.ca/job-1/20250418141950/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2006-32/varizig-varicella-zoster-immune-globulin-prevention-varicella-risk-patients.html?wbdisable=true#ha_snapshot=164711","mimeType":"text/html","statusCode":200}